Products / Services

Product Profile

Platelets
Platelet transfusions are required in a number of conditions to control bleeding episodes. The decision to transfuse should be based on a combination of clinical and laboratory findings rather than on empirical platelet levels. Response to platelet transfusions should be judged on clinical improvement, normalisation of bleeding time, and relative increase in circulating platelet count. Significant increases may not occur in the actively bleeding patient due to rapid utilisation. read more

Leucocyte Depleted Blood Components
In recent years there has been increasing usage of leucocyte depleted cellular blood components. Some countries in the developed world (e.g. United Kingdom, France, Sweden, Canada) have recommended universal prestorage leucocyte depletion of cellular concentrates. Also, the Blood Products Advisory Committee of the FDA in the USA has resolved that the cost benefit ratio associated with leucocyte depletion is sufficiently great to justify universal leucocyte depletion of all cellular components... read more

Paediatric Transfusion Products
The clinical indications for transfusion in neonates and infants may differ from those for adults, as infants are more susceptible to some of the harmful effects of transfusion. For the purpose of these guidelines, neonates are considered to be babies within 4 weeks of their normal gestational age. Infants are babies within the first year of life. read more

Plasma Derived Products
There are wide ranges of plasma products available with specific indications for their use. All plasma products utilise liquid or frozen plasma as their starting material. This may then be subjected to simple physical or more complex chemico-physical processing to produce specific products; the latter are termed plasma derivatives. read more

Red Cell Products WHOLE BLOOD
Whole blood is considered to be a complex tissue from which the numerous and clinically appropriate components are processed. In most transfusion services whole blood is scarce, and is reserved for those few clinical situations where it can be best utilised. Many of the components, particularly clotting factors and platelets, deteriorate within hours of donation. It is necessary to separate, process and store these within 6-12 hours of donation in order to ensure adequate supply of these products for use in the appropriate clinical situation. read more